<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Bonner Ho | Activity</title>
	<link>https://www.catswannabecats.com/members/sudanlute4/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/sudanlute4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Bonner Ho.</description>
	<lastBuildDate>Mon, 29 Jun 2026 10:35:48 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">db71fbc62798779eaab80776cbd25c25</guid>
				<title>Bonner Ho posted an update: We herein report a case of pneumocystis pneumonia (PCP) in a [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23752/</link>
				<pubDate>Sun, 08 Jun 2025 10:28:44 -0400</pubDate>

									<content:encoded><![CDATA[<p>We herein report a case of pneumocystis pneumonia (PCP) in a 77-year-old woman with ovarian cancer who was receiving olaparib therapy. After the patient&#8217;s second relapse of ovarian cancer, she was administered olaparib as maintenance therapy following successful completion of docetaxel and carboplatin therapy. On receiving olaparib, she showed&hellip;<span class="activity-read-more" id="activity-read-more-23752"><a href="https://www.catswannabecats.com/activity/p/23752/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">67f8ff64a0eb9de758e694a9c65565fb</guid>
				<title>Bonner Ho posted an update: Since the approval of intramuscular IFN β-1a, a number of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19661/</link>
				<pubDate>Thu, 05 Jun 2025 08:54:07 -0400</pubDate>

									<content:encoded><![CDATA[<p>Since the approval of intramuscular IFN β-1a, a number of high-efficacy therapies have been approved for MS, though the benefit of these high-efficacy therapies should be balanced against the increased risk of serious adverse events associated with their long-term use. For some subpopulations of patients, including pregnant women, the safety&hellip;<span class="activity-read-more" id="activity-read-more-19661"><a href="https://www.catswannabecats.com/activity/p/19661/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9944aa36e2c4cfbb0a3a699663a67012</guid>
				<title>Bonner Ho posted an update: The sensing of various extrinsic stimuli triggers the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/17804/</link>
				<pubDate>Tue, 03 Jun 2025 09:14:15 -0400</pubDate>

									<content:encoded><![CDATA[<p>The sensing of various extrinsic stimuli triggers the receptor-interacting protein kinase-3 (RIPK3)-mediated signaling pathway, which leads to mixed-lineage kinase-like (MLKL) phosphorylation followed by necroptosis. Although necroptosis is a form of cell death and is involved in inflammatory conditions, the roles of necroptosis in acute&hellip;<span class="activity-read-more" id="activity-read-more-17804"><a href="https://www.catswannabecats.com/activity/p/17804/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">dfaa5c3cf83e634e68d61487080195a7</guid>
				<title>Bonner Ho posted an update: isk detection in these individuals.



Postprandial TG [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/4136/</link>
				<pubDate>Sat, 31 May 2025 12:12:29 -0400</pubDate>

									<content:encoded><![CDATA[<p>isk detection in these individuals.</p>
<p>Postprandial TG testing is likely most useful for individuals with fasting TG concentrations between 70 and 130 mg/dL (0.79-1.50 mmol/L). Outside of this range, postprandial TG responses are largely predictable. Establishing a specific patient group for which postprandial TG testing is most useful may lead to&hellip;<span class="activity-read-more" id="activity-read-more-4136"><a href="https://www.catswannabecats.com/activity/p/4136/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">17fe4353822a18833bd728db7eb058b7</guid>
				<title>Bonner Ho became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4069/</link>
				<pubDate>Sat, 31 May 2025 12:02:35 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>